Exploring the Role of Immunosuppression in Autoimmunity for MS Patients Amid COVID-19

The spread of the COVID-19 pandemic has caused us to reconsider how we treat our patients with multiple sclerosis (MS) and even the role of immunosuppression in autoimmunity. How do we decide what the best course of action is, and what does the limited research available tell us about making the right treatment decision? Those are the exact questions Dr. Amit Bar-Or explores in this interview.

Related Links

Twitter @PennMDForum
See Dr. Bar-Or's Profile


November 17, 2020

Created by

Penn Physician VideoLink